Initiator Pharma publishes year-end report for 2016
February 28, 2017 Financial highlights May - Dec 2016 (comparable figures for 2015 not available[1] ) · Net revenues were TDKK 0 · EBIT was TDKK -887 · Earnings per share was DKK –0.18 · Diluted earnings per share was DKK –0.18 Q4 2016 (comparable figures for Q4 2015 not available1) · Net revenues were TDKK 0 · EBIT was TDKK -713 · Earnings per share was DKK –0.14 · Diluted earnings per share was DKK –0.14 Business highlights in Q4 2016 · Initiator Pharma prepared for the preferential rights share issue of up to SEK 20.5 mill and